Chemclin Diagnostics Co., Ltd.SSE: 688468

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Chemclin Diagnostics Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Chemclin Diagnostics Co., Ltd. announced a performance briefing for the year and first quarter of the following year. The meeting is scheduled to take place online, allowing for interactive communication with investors. The company aims to address common investor concerns regarding its financial results and performance metrics during this session. Participants will include key executives from the company, ensuring direct engagement with shareholders.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Chemclin Diagnostics Co., Ltd. on 6ix

Earlier from Chemclin Diagnostics

Later from Chemclin Diagnostics

All Chemclin Diagnostics news releases